{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:47:51Z","timestamp":1793396871172,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS 2014.11"],"award-info":[{"award-number":["DKS 2014.11"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS 2016.24"],"award-info":[{"award-number":["DKS 2016.24"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The work was supported by the Mediziner Kolleg of the Medical Faculty of the University of Muenster (K.R.) and the Clinician-Scientist Program of the Cells In Motion Cluster of Excellence (J.R.)."},{"name":"The work was supported by the Clinician-Scientist Program of the Cells In Motion Cluster of Excellence, University of Muenster."},{"name":"The work was supported by the Mediziner Kolleg of the Medical Faculty of the University of Muenster."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While survival has improved for Burkitt lymphoma patients, potential differences in outcome between pediatric and adult patients remain unclear. In both age groups, survival remains poor at relapse. Therefore, we conducted a comparative study in a large pediatric cohort, including 191 cases and 97 samples from adults. While<jats:italic>TP53<\/jats:italic>and<jats:italic>CCND3<\/jats:italic>mutation frequencies are not age related, samples from pediatric patients showed a higher frequency of mutations in<jats:italic>ID3<\/jats:italic>,<jats:italic>DDX3X, ARID1A<\/jats:italic>and<jats:italic>SMARCA4<\/jats:italic>, while several genes such as<jats:italic>BCL2<\/jats:italic>and<jats:italic>YY1AP1<\/jats:italic>are almost exclusively mutated in adult patients. An unbiased analysis reveals a transition of the mutational profile between 25 and 40 years of age. Survival analysis in the pediatric cohort confirms that<jats:italic>TP53<\/jats:italic>mutations are significantly associated with higher incidence of relapse (25\u2009\u00b1\u20094% versus 6\u2009\u00b1\u20092%, p-value 0.0002). This identifies a promising molecular marker for relapse incidence in pediatric BL which will be used in future clinical trials.<\/jats:p>","DOI":"10.1038\/s41467-022-31355-8","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T08:04:42Z","timestamp":1657094682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1151-829X","authenticated-orcid":false,"given":"Birgit","family":"Burkhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-8402","authenticated-orcid":false,"given":"Ulf","family":"Michgehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3323-4175","authenticated-orcid":false,"given":"Jonas","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2634-9625","authenticated-orcid":false,"given":"Tabea","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4152-0366","authenticated-orcid":false,"given":"Philipp","family":"Berning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Reutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-525X","authenticated-orcid":false,"given":"Marius","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-4737","authenticated-orcid":false,"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4843-2876","authenticated-orcid":false,"given":"Thomas","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4848-9768","authenticated-orcid":false,"given":"Sandeep","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dugas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5011-0641","authenticated-orcid":false,"given":"Sarah","family":"Sandmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-293X","authenticated-orcid":false,"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0196-2837","authenticated-orcid":false,"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-5021","authenticated-orcid":false,"given":"Wolfgang","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-4117","authenticated-orcid":false,"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4003-6855","authenticated-orcid":false,"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3072-6772","authenticated-orcid":false,"given":"Udo","family":"Kontny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-5687","authenticated-orcid":false,"given":"Mathias","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-514X","authenticated-orcid":false,"given":"Britta","family":"Maecker-Kolhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-2631","authenticated-orcid":false,"given":"Arend","family":"von Stackelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-130X","authenticated-orcid":false,"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-0888","authenticated-orcid":false,"given":"Wilhelm","family":"Woessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myroslav","family":"Zapukhlyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-0133","authenticated-orcid":false,"given":"Michael","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4728-1693","authenticated-orcid":false,"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"31355_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt, B. et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br. J. Haematol. 131, 39\u201349 (2005).","journal-title":"Br. J. Haematol."},{"key":"31355_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2141.2011.09024.x","volume":"156","author":"RR Miles","year":"2012","unstructured":"Miles, R. R., Arnold, S. & Cairo, M. S. Risk factors and treatment of childhood and adolescent Burkitt lymphoma\/leukaemia. Br. J. Haematol. 156, 730\u2013743 (2012).","journal-title":"Br. J. Haematol."},{"key":"31355_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras, L. R. et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J. Clin. 66, 443\u2013459 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"31355_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton, L. M. et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107, 265\u2013276 (2006).","journal-title":"Blood"},{"key":"31355_CR5","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","volume":"18","author":"JL Hecht","year":"2000","unstructured":"Hecht, J. L. & Aster, J. C. Molecular biology of Burkitt\u2019s lymphoma. J. Clin. Oncol. 18, 3707\u20133721 (2000).","journal-title":"J. Clin. Oncol."},{"key":"31355_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3324\/haematol.2016.156885","volume":"102","author":"M Rohde","year":"2017","unstructured":"Rohde, M. et al. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Munster protocols. Haematologica 102, 1091\u20131098 (2017).","journal-title":"Haematologica"},{"key":"31355_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjh.13925","volume":"173","author":"V Havelange","year":"2016","unstructured":"Havelange, V. et al. Genetic differences between paediatric and adult Burkitt lymphomas. Br. J. Haematol. 173, 137\u2013144 (2016).","journal-title":"Br. J. Haematol."},{"key":"31355_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C Lopez","year":"2019","unstructured":"Lopez, C. et al. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat. Commun. 10, 1459 (2019).","journal-title":"Nat. Commun."},{"key":"31355_CR9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love, C. et al. The genetic landscape of mutations in Burkitt lymphoma. Nat. Genet. 44, 1321\u20131325 (2012).","journal-title":"Nat. Genet."},{"key":"31355_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter, J. et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat. Genet. 44, 1316\u20131320 (2012).","journal-title":"Nat. Genet."},{"key":"31355_CR11","doi-asserted-by":"publisher","unstructured":"Reutter, K. et al. Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma. Leukemia https:\/\/doi.org\/10.1038\/s41375-020-0862-5 (2020).","DOI":"10.1038\/s41375-020-0862-5"},{"key":"31355_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"BM Grande","year":"2019","unstructured":"Grande, B. M. et al. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 133, 1313\u20131324 (2019).","journal-title":"Blood"},{"key":"31355_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bjh.13849","volume":"172","author":"M Forero-Castro","year":"2016","unstructured":"Forero-Castro, M. et al. The presence of genomic imbalances is associated with poor outcome in patients with Burkitt lymphoma treated with dose-intensive chemotherapy including rituximab. Br. J. Haematol. 172, 428\u2013438 (2016).","journal-title":"Br. J. Haematol."},{"key":"31355_CR14","doi-asserted-by":"publisher","unstructured":"Burkhardt, B. et al. Treatment and outcome analysis of 639 relapsed non-Hodgkin lymphomas in children and adolescents and resulting treatment recommendations. Cancers 13, https:\/\/doi.org\/10.3390\/cancers13092075 (2021).","DOI":"10.3390\/cancers13092075"},{"key":"31355_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/MOH.0b013e3281bccdee","volume":"14","author":"JT Yustein","year":"2007","unstructured":"Yustein, J. T. & Dang, C. V. Biology and treatment of Burkitt\u2019s lymphoma. Curr. Opin. Hematol. 14, 375\u2013381 (2007).","journal-title":"Curr. Opin. Hematol."},{"key":"31355_CR16","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","volume":"28","author":"A Meinhardt","year":"2010","unstructured":"Meinhardt, A. et al. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin\u2019s lymphoma and Burkitt leukemia. J. Clin. Oncol. 28, 3115\u20133121 (2010).","journal-title":"J. Clin. Oncol."},{"key":"31355_CR17","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","volume":"382","author":"V Minard-Colin","year":"2020","unstructured":"Minard-Colin, V. et al. Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children. N. Engl. J. Med. 382, 2207\u20132219 (2020).","journal-title":"N. Engl. J. Med."},{"key":"31355_CR18","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","volume":"124","author":"D Hoelzer","year":"2014","unstructured":"Hoelzer, D. et al. Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 124, 3870\u20133879 (2014).","journal-title":"Blood"},{"key":"31355_CR19","doi-asserted-by":"publisher","first-page":"e27873","DOI":"10.1002\/pbc.27873","volume":"66","author":"C Rigaud","year":"2019","unstructured":"Rigaud, C. et al. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: a report from the French LMB study. Pediatr. Blood Cancer 66, e27873 (2019).","journal-title":"Pediatr. Blood Cancer"},{"key":"31355_CR20","first-page":"1124","volume":"135","author":"W Woessmann","year":"2020","unstructured":"Woessmann, W. et al. Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy. Blood 135, 1124\u20131132 (2020).","journal-title":"Blood"},{"key":"31355_CR21","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1200\/JCO.1996.14.9.2465","volume":"14","author":"JW Sweetenham","year":"1996","unstructured":"Sweetenham, J. W. et al. Adult Burkitt\u2019s and Burkitt-like non-Hodgkin\u2019s lymphoma-outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 14, 2465\u20132472 (1996).","journal-title":"J. Clin. Oncol."},{"key":"31355_CR22","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1182\/blood-2011-05-349662","volume":"119","author":"KE Deffenbacher","year":"2012","unstructured":"Deffenbacher, K. E. et al. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood 119, 3757\u20133766 (2012).","journal-title":"Blood"},{"key":"31355_CR23","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"31355_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029\u20131041.e1021 (2017).","journal-title":"Cell"},{"key":"31355_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","volume":"155","author":"JD Schiffman","year":"2011","unstructured":"Schiffman, J. D. et al. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br. J. Haematol. 155, 477\u2013486 (2011).","journal-title":"Br. J. Haematol."},{"key":"31355_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116\u2013120 (2012).","journal-title":"Nature"},{"key":"31355_CR27","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1091\/mbc.e07-12-1264","volume":"19","author":"MC Lai","year":"2008","unstructured":"Lai, M. C., Lee, Y. H. & Tarn, W. Y. The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol. Biol. Cell 19, 3847\u20133858 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"31355_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature13765","volume":"516","author":"JR Muppidi","year":"2014","unstructured":"Muppidi, J. R. et al. Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma. Nature 516, 254\u2013258 (2014).","journal-title":"Nature"},{"key":"31355_CR29","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1038\/onc.2015.442","volume":"35","author":"M O\u2019Hayre","year":"2016","unstructured":"O\u2019Hayre, M. et al. Inactivating mutations in GNA13 and RHOA in Burkitt\u2019s lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Galpha13\/RhoA axis in B cells. Oncogene 35, 3771\u20133780 (2016).","journal-title":"Oncogene"},{"key":"31355_CR30","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1038\/onc.2014.438","volume":"34","author":"X Zhao","year":"2015","unstructured":"Zhao, X. et al. Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma. Oncogene 34, 5095\u20135104 (2015).","journal-title":"Oncogene"},{"key":"31355_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4161\/cc.6.2.3742","volume":"6","author":"HB Koch","year":"2007","unstructured":"Koch, H. B. et al. Large-scale identification of c-MYC-associated proteins using a combined TAP\/MudPIT approach. Cell Cycle 6, 205\u2013217 (2007).","journal-title":"Cell Cycle"},{"key":"31355_CR32","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1038\/sj.onc.1206645","volume":"22","author":"JR Evans","year":"2003","unstructured":"Evans, J. R. et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22, 8012\u20138020 (2003).","journal-title":"Oncogene"},{"key":"31355_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41375-019-0628-0","volume":"34","author":"F Gehringer","year":"2020","unstructured":"Gehringer, F., Weissinger, S. E., M\u00f6ller, P., Wirth, T. & Ushmorov, A. Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma. Leukemia 34, 857\u2013871 (2020).","journal-title":"Leukemia"},{"key":"31355_CR34","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","volume":"130","author":"A Bouska","year":"2017","unstructured":"Bouska, A. et al. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. Blood 130, 1819\u20131831 (2017).","journal-title":"Blood"},{"key":"31355_CR35","doi-asserted-by":"publisher","unstructured":"Thomas, N. et al. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.12.05.21267216 (2021).","DOI":"10.1101\/2021.12.05.21267216"},{"key":"31355_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjh.17874","volume":"196","author":"J Richter","year":"2022","unstructured":"Richter, J. et al. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br. J. Haematol. 196, 681\u2013689 (2022).","journal-title":"Br. J. Haematol."},{"key":"31355_CR37","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/j.molcel.2021.07.041","volume":"81","author":"C Gong","year":"2021","unstructured":"Gong, C. et al. Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis. Mol. Cell 81, 4059\u20134075.e4011 (2021).","journal-title":"Mol. Cell"},{"key":"31355_CR38","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41588-019-0477-9","volume":"51","author":"S Schick","year":"2019","unstructured":"Schick, S. et al. Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers. Nat. Genet. 51, 1399\u20131410 (2019).","journal-title":"Nat. Genet."},{"key":"31355_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejca.2019.01.013","volume":"110","author":"ADJ Pearson","year":"2019","unstructured":"Pearson, A. D. J. et al. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children. Eur. J. Cancer 110, 74\u201385 (2019).","journal-title":"Eur. J. Cancer"},{"key":"31355_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/hon.2437_3","volume":"35","author":"F Morschhauser","year":"2017","unstructured":"Morschhauser, F. et al. Interim report from a phase 2 multicenter study of tazemetostat, an EZH2 inhibitor, in patients with relapsed or refractory B-cell non-Hodgkin lymphomas. Hematological Oncol. 35, 24\u201325 (2017).","journal-title":"Hematological Oncol."},{"key":"31355_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7118","volume":"6","author":"RL Chandler","year":"2015","unstructured":"Chandler, R. L. et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat. Commun. 6, 6118 (2015).","journal-title":"Nat. Commun."},{"key":"31355_CR42","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/modpathol.2013.216","volume":"27","author":"HN Huang","year":"2014","unstructured":"Huang, H. N., Lin, M. C., Huang, W. C., Chiang, Y. C. & Kuo, K. T. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma. Mod. Pathol. 27, 983\u2013990 (2014).","journal-title":"Mod. Pathol."},{"key":"31355_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10688","volume":"481","author":"S Duan","year":"2012","unstructured":"Duan, S. et al. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature 481, 90\u201393 (2012).","journal-title":"Nature"},{"key":"31355_CR44","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","volume":"121","author":"DL Trinh","year":"2013","unstructured":"Trinh, D. L. et al. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood 121, 3666\u20133674 (2013).","journal-title":"Blood"},{"key":"31355_CR45","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","volume":"96","author":"WH Biggs 3rd","year":"1999","unstructured":"Biggs, W. H. 3rd, Meisenhelder, J., Hunter, T., Cavenee, W. K. & Arden, K. C. Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA 96, 7421\u20137426 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31355_CR46","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/bloodadvances.2018029546","volume":"3","author":"P Zhou","year":"2019","unstructured":"Zhou, P. et al. Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif. Blood Adv. 3, 2118\u20132127 (2019).","journal-title":"Blood Adv."},{"key":"31355_CR47","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1074\/jbc.M609001200","volume":"282","author":"WM Abida","year":"2007","unstructured":"Abida, W. M., Nikolaev, A., Zhao, W., Zhang, W. & Gu, W. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J. Biol. Chem. 282, 1797\u20131804 (2007).","journal-title":"J. Biol. Chem."},{"key":"31355_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00277-016-2653-7","volume":"95","author":"MC Robaina","year":"2016","unstructured":"Robaina, M. C. et al. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis. Ann. Hematol. 95, 881\u2013891 (2016).","journal-title":"Ann. Hematol."},{"key":"31355_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.celrep.2016.05.084","volume":"16","author":"D Benhamou","year":"2016","unstructured":"Benhamou, D. et al. A c-Myc\/miR17-92\/Pten axis controls PI3K-mediated positive and negative selection in B cell development and reconstitutes CD19 deficiency. Cell Rep. 16, 419\u2013431 (2016).","journal-title":"Cell Rep."},{"key":"31355_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405\u2013414 (2008).","journal-title":"Nat. Immunol."},{"key":"31355_CR51","doi-asserted-by":"publisher","unstructured":"Newman, A. M. et al. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia https:\/\/doi.org\/10.1038\/s41375-021-01444-6 (2021).","DOI":"10.1038\/s41375-021-01444-6"},{"key":"31355_CR52","doi-asserted-by":"crossref","unstructured":"Sallman, D. A. et al. Eprenetapopt (APR-246) and azacitidine in TP53-mutant myelodysplastic syndromes. J. Clin. Oncol. 39, 1584\u20131594 (2021).","DOI":"10.1200\/JCO.20.02341"},{"key":"31355_CR53","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","volume":"105","author":"W Woessmann","year":"2005","unstructured":"Woessmann, W. et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 105, 948\u2013958 (2005).","journal-title":"Blood"},{"key":"31355_CR54","unstructured":"Krueger, F. Trim Galore!: A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files. Babraham Institute https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/trim_galore\/ (2015)."},{"key":"31355_CR55","doi-asserted-by":"publisher","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"31355_CR56","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc (2010)."},{"key":"31355_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. methods 12, 357\u2013360 (2015).","journal-title":"Nat. methods"},{"key":"31355_CR58","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1101\/gr.213611.116","volume":"27","author":"VA Schneider","year":"2017","unstructured":"Schneider, V. A. et al. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res. 27, 849\u2013864 (2017).","journal-title":"Genome Res."},{"key":"31355_CR59","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"31355_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"31355_CR61","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"31355_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"31355_CR63","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nmeth.3622","volume":"12","author":"W Zhou","year":"2015","unstructured":"Zhou, W. et al. TransVar: a multilevel variant annotator for precision genomics. Nat. Methods 12, 1002\u20131003 (2015).","journal-title":"Nat. Methods"},{"key":"31355_CR64","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 44, D733\u2013D745 (2016).","journal-title":"Nucleic Acids Res."},{"key":"31355_CR65","doi-asserted-by":"publisher","first-page":"D110","DOI":"10.1093\/nar\/gks1058","volume":"41","author":"JM Rodriguez","year":"2013","unstructured":"Rodriguez, J. M. et al. APPRIS: annotation of principal and alternative splice isoforms. Nucleic Acids Res. 41, D110\u2013D117 (2013).","journal-title":"Nucleic Acids Res."},{"key":"31355_CR66","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"31355_CR67","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"31355_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0973-5","volume":"17","author":"BS Pedersen","year":"2016","unstructured":"Pedersen, B. S., Layer, R. M. & Quinlan, A. R. Vcfanno: fast, flexible annotation of genetic variants. Genome Biol. 17, 118 (2016).","journal-title":"Genome Biol."},{"key":"31355_CR69","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"31355_CR70","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinforma. 14, 178\u2013192 (2013).","journal-title":"Brief. Bioinforma."},{"key":"31355_CR71","unstructured":"Picard Toolkit: a set of command line tools (in Java) for manipulating high-throughput sequencing (HTS) data and formats such as SAM\/BAM\/CRAM and VCF. Broad Institute, GitHub Repository. https:\/\/broadinstitute.github.io\/picard (2019)."},{"key":"31355_CR72","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"31355_CR73","doi-asserted-by":"publisher","unstructured":"Tange, O. GNU Parallel 2018, https:\/\/doi.org\/10.5281\/zenodo.1146014 (2018).","DOI":"10.5281\/zenodo.1146014"},{"key":"31355_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou, X. et al. Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat. Genet. 48, 4\u20136 (2016).","journal-title":"Nat. Genet."},{"key":"31355_CR75","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31355_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"31355_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira, B. et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat. Commun. 7, 11479 (2016).","journal-title":"Nat. Commun."},{"key":"31355_CR78","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"31355_CR79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"31355_CR80","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31355-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T15:36:08Z","timestamp":1727537768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31355-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31355"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31355-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Torsten Haferlach and Wolfgang Kern declare partial ownership of MLL M\u00fcnchner Leuk\u00e4mielabor GmbH. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3881"}}